Impact of a supportive care service for cancer outpatients: management and reduction of hospitalizations. Preliminary results of an integrated model of care

2016 ◽  
Vol 25 (1) ◽  
pp. 209-212 ◽  
Author(s):  
A. Antonuzzo ◽  
E. Vasile ◽  
A. Sbrana ◽  
M. Lucchesi ◽  
L. Galli ◽  
...  
2018 ◽  
Vol 36 (34_suppl) ◽  
pp. 99-99
Author(s):  
Sarah Loschiavo ◽  
Trena Stoute ◽  
Karen Hook

99 Background: Timely incorporation of palliative services with chemotherapy treatment has become a new standard of care for oncology patients based on evidence-driven national clinical practice guidelines. However, best practices for service integration are not known, particularly for small academic centers. In our 224 bed university hospital, we hypothesized that advertisement, responsiveness to needs and service integration would result in increased utilization of palliative and supportive care. We report the process of developing our Integrated Model of Care. Methods: The program began with a 1.0 FTE APRN boarded as a FNP and certified as an advanced hospice and palliative nurse. The goal was to identify opportunities for her integration within the outpatient cancer center. A needs-assessment survey was sent to medical oncology faculty with the following items: proposed change in service name, care areas of greatest need, limitations to providing palliative care, additional growth opportunities. The Interdisciplinary Supportive Care Team was created utilizing existing staff. One year of billed consults were reviewed. The APRN attended tumor boards, team meetings, biweekly Interdisciplinary Team Meetings, communicated directly with the Inpatient Hem/Onc Team and provided educational sessions. Results: Needs assessment survey and service name change proposal sent to 14 oncology providers: 50% completed survey; seven responded YES to name change; zero providers responded NO. Of the 489 consults billed within the 1st year of service, 249 were inpatient and 240 outpatients. 168 individual patients were referred; > 72 patients were referred to palliative/hospice services; > 82 patients died. One year satisfaction survey; 17 respondents; 88.23% were satisficed and 100% would consult again. Conclusions: Medical oncology faculty at our institution responded favorably to the development of a designated “Oncology Supportive Care Service” evidenced by increased consultation and utilization of services. Optimizing clinical infrastructure, processes, education and research has led to the success of this integrated care model, lending to recruitment of additional allied health professionals and ongoing program growth.


1988 ◽  
Vol 16 (4) ◽  
pp. 410
Author(s):  
Brenda E. Field ◽  
Lynn Devich ◽  
Marilyn T. Haupt ◽  
Richard W. Carlson

2018 ◽  
Vol 36 (34_suppl) ◽  
pp. 134-134
Author(s):  
Finly Zachariah ◽  
Denise Morse ◽  
Lucia Kinsey ◽  
Marianna Koczywas ◽  
Ravi Salgia ◽  
...  

134 Background: Palliative care (PC) has shown benefits to inpatient length of stay (LOS), symptom burden reduction, utilization decrease, and time on hospice. It has shown less impact on the rate of hospice referrals. We assessed the impact of an integrated care model on these outcomes. Methods: From Jan-July, 2018, the Department of Supportive Care Medicine collaborated with medical oncology (med onc), nursing and administration to create the Integrated Care Service (ICS). Multi-disciplinary rounds include med onc, supportive care (PC, social work, spiritual care, psychiatry, psychology, hospice liaison), nursing, case management, nutrition, and physical and occupational therapy. The admission criteria include: 1) Later-stage disease; 2) Non-curative intent therapy; 3) High distress burden; and 4) Poor prognosis. The ICS was designed to have geographic co-location, morning PC and med onc rounds, multidisciplinary rounds, and post-acute management. The ICS was compared with other med onc patients (non-ICS) and Mantel-Haenszel Chi-Square statistical significance (p<0.05) was calculated using Epi Info StatCalc. Results: In 6 months, 190 med onc patients (pts) were admitted to ICS versus 537 non-ICS pts. Compared with non-ICS, the ICS pts had a higher Case Mix Index (1.81 vs. 1.56) and metastatic disease incidence (95% vs. 78%, p=0.008). Discharge to hospice was higher from ICS versus non-ICS (23% vs. 7%, p=<0.001), and average time on hospice increased from 9 to 15 days. No chemotherapy was given in the last two weeks of life to any pts on ICS (0 vs. 6 non-ICS pts). Length of stay (LOS) was higher on ICS as compared to non-ICS (8.45 vs. 5.26 days) and readmission rates were similar (12% vs. 13%). Conclusions: For medical oncology pts in a comprehensive cancer center, the ICS, an integrated, multidisciplinary supportive care service, significantly improved discharge rates to hospice, increased LOS on hospice by almost a week, avoided patients receiving chemotherapy, and maintained similar readmission rates. LOS was higher for complex ICS patients as compared to non-ICS. Based on this pilot, the ICS is planning for expansion to include hematology and surgical services.


2017 ◽  
Vol 26 (7) ◽  
pp. 676-679 ◽  
Author(s):  
Rosa Marina Avilla ◽  
Juliana Surjan ◽  
Maria de Fátima Ratto Padin ◽  
Martha Canfield ◽  
Ronaldo Ramos Laranjeira ◽  
...  

2020 ◽  
Author(s):  
Jane Whitehurst ◽  
Sue Goodall ◽  
Ellie Hayter ◽  
Kevin Blackett

2020 ◽  
Vol 73 (1) ◽  
pp. 77-86
Author(s):  
Lori A. Newkirk ◽  
Virginia L. Dao ◽  
Joshua T. Jordan ◽  
Loren I. Alving ◽  
Helen D. Davies ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document